These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 7951119
1. Comparison of auto versus allografting as consolidation of primary treatments in advanced neuroblastoma over one year of age at diagnosis: report from the European Group for Bone Marrow Transplantation. Ladenstein R, Lasset C, Hartmann O, Klingebiel T, Bouffet E, Gadner H, Paolucci P, Burdach S, Chauvin F, Pinkerton R. Bone Marrow Transplant; 1994 Jul; 14(1):37-46. PubMed ID: 7951119 [Abstract] [Full Text] [Related]
2. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy. Ortega JJ, Díaz de Heredia C, Olivé T, Bastida P, Llort A, Armadans L, Torrabadella M, Massuet L. Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268 [Abstract] [Full Text] [Related]
3. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children. Parsons SK, Castellino SM, Lehmann LE, Eickhoff CE, Tarbell NJ, Sallan SE, Weinstein HJ, Billett AL. Bone Marrow Transplant; 1996 May; 17(5):763-8. PubMed ID: 8733695 [Abstract] [Full Text] [Related]
4. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT). Gorin NC, Labopin M, Fouillard L, Meloni G, Frassoni F, Iriondo A, Brunet Mauri S, Goldstone AH, Harousseau JL, Reiffers J, Esperou-Bourdeau H, Gluckman E. Bone Marrow Transplant; 1996 Jul; 18(1):111-7. PubMed ID: 8832003 [Abstract] [Full Text] [Related]
5. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT. Solano C, Martinez C, Brunet S, Tomás JF, Urbano-Ispizua A, Zuazu J, Ojeda E, Bargay J, Moraleda JM, Bailen A, Sierra J, García-Conde J, Rozman C. Bone Marrow Transplant; 1998 Dec; 22(12):1129-35. PubMed ID: 9894714 [Abstract] [Full Text] [Related]
6. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants. Al-Kasim FA, Thornley I, Rolland M, Lau W, Tsang R, Freedman MH, Saunders EF, Calderwood S, Doyle JJ. Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456 [Abstract] [Full Text] [Related]
7. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease. Aschan J, Ringdén O. Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365 [Abstract] [Full Text] [Related]
8. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). Frassoni F, Labopin M, Gluckman E, Prentice HG, Vernant JP, Zwaan F, Granena A, Gahrton G, De Witte T, Gratwohl A, Reiffers J, Gorin NC. Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048 [Abstract] [Full Text] [Related]
9. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia]. Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK. Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125 [Abstract] [Full Text] [Related]
10. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation. Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S. Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323 [Abstract] [Full Text] [Related]
11. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population. Schönberger S, Niehues T, Meisel R, Bernbeck B, Laws HJ, Kögler G, Enzmann J, Wernet P, Göbel U, Dilloo D. Klin Padiatr; 2004 Jan; 216(6):356-63. PubMed ID: 15565551 [Abstract] [Full Text] [Related]
13. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP). Michel G, Leverger G, Leblanc T, Nelken B, Baruchel A, Landman-Parker J, Thuret I, Bergeron C, Bordigoni P, Esperou-Bourdeau H, Perel Y, Vannier JP, Schaison G. Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165 [Abstract] [Full Text] [Related]
14. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma. Kamani N, August CS, Bunin N, Leahey A, Bayever E, Goldwein J, Zusman J, Evans AE, Angio GD. Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093 [Abstract] [Full Text] [Related]
15. Long-term follow-up of allogeneic bone marrow transplantation in patients with poor prognosis non-Hodgkin's lymphoma. Bernard M, Dauriac C, Drénou B, Leberre C, Branger B, Fauchet R, Le Prisé PY, Lamy T. Bone Marrow Transplant; 1999 Feb; 23(4):329-33. PubMed ID: 10100576 [Abstract] [Full Text] [Related]
16. Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukemia. Vicent MG, Madero L, Ortega JJ, Martinez A, Gomez P, Verdeguer A, Badell I, Muñoz A, Olive T, Maldonado MS, Bureo E, Cubells J, Diaz MA, Spanish Working Party for BMT in Children (GETMON). Bone Marrow Transplant; 2002 Jul; 30(1):9-13. PubMed ID: 12105771 [Abstract] [Full Text] [Related]
17. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation. Romano V, Castagnola E, Dallorso S, Lanino E, Calvi A, Silvestro S, Morreale G, Giacchino R, Dini G. Bone Marrow Transplant; 1999 Feb; 23(3):271-5. PubMed ID: 10084259 [Abstract] [Full Text] [Related]
18. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran. Zakerinia M, Khojasteh HN, Ramzi M, Haghshenas M. Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149 [Abstract] [Full Text] [Related]
19. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major. Ghavamzadeh A, Iravani M, Ashouri A, Mousavi SA, Mahdavi N, Shamshiri A, Hadjibabaie M, Namdar R, Nedaeifard L, Ghaffari H, Alimoghaddam K. Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896 [Abstract] [Full Text] [Related]
20. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine. Mehta J, Powles R, Treleaven J, Horton C, Tait D, Meller S, Pinkerton CR, Middleton G, Eisen T, Singhal S. Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189 [Abstract] [Full Text] [Related] Page: [Next] [New Search]